Product Information
ERYTHROMYCIN 2% SOLUTION is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3482 per ML under NDC 45802003846. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
20 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802003846
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA063038On Market Since
12/19/2011
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 2% SOLUTION has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3482 per ML |
|---|---|
| All-time high | $0.6289 (Feb 12, 2014) |
| All-time low | $0.2616 (May 22, 2024) |
| 52-week high | $0.3907 |
| 52-week low | $0.3361 |
| Median price | $0.4799 |
| Average price | $0.4842 |
| Largest weekly change | +41.1% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the erythromycin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 2% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 2% SOLUTION, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3482 per ML (NDC 45802003846), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN 2% SOLUTION changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 2% SOLUTION has declined 42.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 2% SOLUTION?
Since Nov 28, 2013, the NADAC for ERYTHROMYCIN 2% SOLUTION has ranged from a low of $0.2616 (May 22, 2024) to a high of $0.6289 (Feb 12, 2014), with a median of $0.4799 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 2% SOLUTION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ERYTHROMYCIN 2% SOLUTION, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN 2% SOLUTION?
ERYTHROMYCIN 2% SOLUTION (NDC 45802003846) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification